Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Polysaccharide Hemostatic Powder Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Polysaccharide Hemostatic Powder Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 150 Pages
Report ld: 5344957
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Polysaccharide Hemostatic Powder Market Size(US$)
CAGR 2025-2031
7.8%
Market Size,2031
USD 451
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 287 million
Market Forecast in 2031(Value)
US$ 451 million
CAGR
7.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Polysaccharide Hemostatic Powder market is projected to grow from US$ 269 million in 2024 to US$ 451 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A polysaccharide hemostatic powder can be used as an adjunctive hemostat to facilitate control of bleeding from capillary, venous or arteriolar vessels to address low-grade intraoperative bleeding.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Polysaccharide Hemostatic Powder is an innovative hemostatic product formulated primarily with natural polysaccharides, known for their ability to promote blood clotting and wound healing. As awareness of health and a demand for natural and safe products continue to rise, the market has shown a significant interest in Polysaccharide Hemostatic Powder. Its distinctive hemostatic mechanism and low irritability make it an ideal choice in fields such as surgical procedures, trauma management, and emergency care. In recent years, the clinical efficacy of Polysaccharide Hemostatic Powder has been well-documented, gradually establishing it as a trusted option among medical institutions and consumers alike.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Polysaccharide Hemostatic Powder market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- EndoClot Plus
- Baxter
- Hemostasis, LLC
- Singclean Medical Products
- Johnson & Johnson
- BD
- Zhonghui Shengxi
- Beijing Tech-Bio-Med Medical Equipment Co.,Ltd.
- Saikesaisi Holdings Group
- Boz Medical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Polysaccharide Hemostatic Powder
- Absorbable Modified Polymer
Segment by Application
- Hospital
- Clinic
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Polysaccharide Hemostatic Powder study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Polysaccharide Hemostatic Powder: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Polysaccharide Hemostatic Powder Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Polysaccharide Hemostatic Powder
1.2.3 Absorbable Modified Polymer
1.3 Market Segmentation by Application
1.3.1 Global Polysaccharide Hemostatic Powder Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Polysaccharide Hemostatic Powder Revenue Estimates and Forecasts 2020-2031
2.2 Global Polysaccharide Hemostatic Powder Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Polysaccharide Hemostatic Powder Sales Estimates and Forecasts 2020-2031
2.4 Global Polysaccharide Hemostatic Powder Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Polysaccharide Hemostatic Powder Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Polysaccharide Hemostatic Powder Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Polysaccharide Hemostatic Powder Market Size by Manufacturers
3.5.2 Absorbable Modified Polymer Market Size by Manufacturers
3.6 Global Polysaccharide Hemostatic Powder Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Polysaccharide Hemostatic Powder Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Polysaccharide Hemostatic Powder Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Polysaccharide Hemostatic Powder Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Polysaccharide Hemostatic Powder Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Polysaccharide Hemostatic Powder Sales and Revenue by Type (2020-2031)
6.4 North America Polysaccharide Hemostatic Powder Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Polysaccharide Hemostatic Powder Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Polysaccharide Hemostatic Powder Sales and Revenue by Type (2020-2031)
7.4 Europe Polysaccharide Hemostatic Powder Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Polysaccharide Hemostatic Powder Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Polysaccharide Hemostatic Powder Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Polysaccharide Hemostatic Powder Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Polysaccharide Hemostatic Powder Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Polysaccharide Hemostatic Powder Sales and Revenue by Type (2020-2031)
9.4 Central and South America Polysaccharide Hemostatic Powder Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Polysaccharide Hemostatic Powder Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Polysaccharide Hemostatic Powder Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Polysaccharide Hemostatic Powder Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Polysaccharide Hemostatic Powder Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 EndoClot Plus
11.1.1 EndoClot Plus Corporation Information
11.1.2 EndoClot Plus Business Overview
11.1.3 EndoClot Plus Polysaccharide Hemostatic Powder Product Models, Descriptions and Specifications
11.1.4 EndoClot Plus Polysaccharide Hemostatic Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 EndoClot Plus Polysaccharide Hemostatic Powder Sales by Product in 2024
11.1.6 EndoClot Plus Polysaccharide Hemostatic Powder Sales by Application in 2024
11.1.7 EndoClot Plus Polysaccharide Hemostatic Powder Sales by Geographic Area in 2024
11.1.8 EndoClot Plus Polysaccharide Hemostatic Powder SWOT Analysis
11.1.9 EndoClot Plus Recent Developments
11.2 Baxter
11.2.1 Baxter Corporation Information
11.2.2 Baxter Business Overview
11.2.3 Baxter Polysaccharide Hemostatic Powder Product Models, Descriptions and Specifications
11.2.4 Baxter Polysaccharide Hemostatic Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Baxter Polysaccharide Hemostatic Powder Sales by Product in 2024
11.2.6 Baxter Polysaccharide Hemostatic Powder Sales by Application in 2024
11.2.7 Baxter Polysaccharide Hemostatic Powder Sales by Geographic Area in 2024
11.2.8 Baxter Polysaccharide Hemostatic Powder SWOT Analysis
11.2.9 Baxter Recent Developments
11.3 Hemostasis, LLC
11.3.1 Hemostasis, LLC Corporation Information
11.3.2 Hemostasis, LLC Business Overview
11.3.3 Hemostasis, LLC Polysaccharide Hemostatic Powder Product Models, Descriptions and Specifications
11.3.4 Hemostasis, LLC Polysaccharide Hemostatic Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Hemostasis, LLC Polysaccharide Hemostatic Powder Sales by Product in 2024
11.3.6 Hemostasis, LLC Polysaccharide Hemostatic Powder Sales by Application in 2024
11.3.7 Hemostasis, LLC Polysaccharide Hemostatic Powder Sales by Geographic Area in 2024
11.3.8 Hemostasis, LLC Polysaccharide Hemostatic Powder SWOT Analysis
11.3.9 Hemostasis, LLC Recent Developments
11.4 Singclean Medical Products
11.4.1 Singclean Medical Products Corporation Information
11.4.2 Singclean Medical Products Business Overview
11.4.3 Singclean Medical Products Polysaccharide Hemostatic Powder Product Models, Descriptions and Specifications
11.4.4 Singclean Medical Products Polysaccharide Hemostatic Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Singclean Medical Products Polysaccharide Hemostatic Powder Sales by Product in 2024
11.4.6 Singclean Medical Products Polysaccharide Hemostatic Powder Sales by Application in 2024
11.4.7 Singclean Medical Products Polysaccharide Hemostatic Powder Sales by Geographic Area in 2024
11.4.8 Singclean Medical Products Polysaccharide Hemostatic Powder SWOT Analysis
11.4.9 Singclean Medical Products Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Polysaccharide Hemostatic Powder Product Models, Descriptions and Specifications
11.5.4 Johnson & Johnson Polysaccharide Hemostatic Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Johnson & Johnson Polysaccharide Hemostatic Powder Sales by Product in 2024
11.5.6 Johnson & Johnson Polysaccharide Hemostatic Powder Sales by Application in 2024
11.5.7 Johnson & Johnson Polysaccharide Hemostatic Powder Sales by Geographic Area in 2024
11.5.8 Johnson & Johnson Polysaccharide Hemostatic Powder SWOT Analysis
11.5.9 Johnson & Johnson Recent Developments
11.6 BD
11.6.1 BD Corporation Information
11.6.2 BD Business Overview
11.6.3 BD Polysaccharide Hemostatic Powder Product Models, Descriptions and Specifications
11.6.4 BD Polysaccharide Hemostatic Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 BD Recent Developments
11.7 Zhonghui Shengxi
11.7.1 Zhonghui Shengxi Corporation Information
11.7.2 Zhonghui Shengxi Business Overview
11.7.3 Zhonghui Shengxi Polysaccharide Hemostatic Powder Product Models, Descriptions and Specifications
11.7.4 Zhonghui Shengxi Polysaccharide Hemostatic Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Zhonghui Shengxi Recent Developments
11.8 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd.
11.8.1 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Corporation Information
11.8.2 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Business Overview
11.8.3 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Product Models, Descriptions and Specifications
11.8.4 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Recent Developments
11.9 Saikesaisi Holdings Group
11.9.1 Saikesaisi Holdings Group Corporation Information
11.9.2 Saikesaisi Holdings Group Business Overview
11.9.3 Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Product Models, Descriptions and Specifications
11.9.4 Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Saikesaisi Holdings Group Recent Developments
11.10 Boz Medical
11.10.1 Boz Medical Corporation Information
11.10.2 Boz Medical Business Overview
11.10.3 Boz Medical Polysaccharide Hemostatic Powder Product Models, Descriptions and Specifications
11.10.4 Boz Medical Polysaccharide Hemostatic Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Boz Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Polysaccharide Hemostatic Powder Industry Chain
12.2 Polysaccharide Hemostatic Powder Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Polysaccharide Hemostatic Powder Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Polysaccharide Hemostatic Powder Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Polysaccharide Hemostatic Powder Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Polysaccharide Hemostatic Powder Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Polysaccharide Hemostatic Powder Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Polysaccharide Hemostatic Powder Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Polysaccharide Hemostatic Powder Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Polysaccharide Hemostatic Powder Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Polysaccharide Hemostatic Powder Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Polysaccharide Hemostatic Powder Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Polysaccharide Hemostatic Powder Sales by Region (2020-2025) & (K Units)
Table 8. Global Polysaccharide Hemostatic Powder Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Polysaccharide Hemostatic Powder Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Polysaccharide Hemostatic Powder Sales Share by Manufacturers (2020-2025)
Table 12. Global Polysaccharide Hemostatic Powder Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Polysaccharide Hemostatic Powder Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Polysaccharide Hemostatic Powder by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polysaccharide Hemostatic Powder as of 2024)
Table 16. Global Polysaccharide Hemostatic Powder Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Polysaccharide Hemostatic Powder Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Polysaccharide Hemostatic Powder Manufacturing Base and Headquarters
Table 19. Global Polysaccharide Hemostatic Powder Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Polysaccharide Hemostatic Powder Sales by Type (2020-2025) & (K Units)
Table 23. Global Polysaccharide Hemostatic Powder Sales by Type (2026-2031) & (K Units)
Table 24. Global Polysaccharide Hemostatic Powder Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Polysaccharide Hemostatic Powder Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Polysaccharide Hemostatic Powder ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Polysaccharide Hemostatic Powder Sales by Application (2020-2025) & (K Units)
Table 29. Global Polysaccharide Hemostatic Powder Sales by Application (2026-2031) & (K Units)
Table 30. Polysaccharide Hemostatic Powder High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Polysaccharide Hemostatic Powder Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Polysaccharide Hemostatic Powder Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Polysaccharide Hemostatic Powder ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Polysaccharide Hemostatic Powder Growth Accelerators and Market Barriers
Table 37. North America Polysaccharide Hemostatic Powder Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Polysaccharide Hemostatic Powder Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Polysaccharide Hemostatic Powder Growth Accelerators and Market Barriers
Table 40. Europe Polysaccharide Hemostatic Powder Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Polysaccharide Hemostatic Powder Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Polysaccharide Hemostatic Powder Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Polysaccharide Hemostatic Powder Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Polysaccharide Hemostatic Powder Growth Accelerators and Market Barriers
Table 45. Southeast Asia Polysaccharide Hemostatic Powder Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Polysaccharide Hemostatic Powder Investment Opportunities and Key Challenges
Table 47. Central and South America Polysaccharide Hemostatic Powder Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Polysaccharide Hemostatic Powder Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Polysaccharide Hemostatic Powder Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. EndoClot Plus Corporation Information
Table 51. EndoClot Plus Description and Major Businesses
Table 52. EndoClot Plus Product Models, Descriptions and Specifications
Table 53. EndoClot Plus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. EndoClot Plus Sales Value Proportion by Product in 2024
Table 55. EndoClot Plus Sales Value Proportion by Application in 2024
Table 56. EndoClot Plus Sales Value Proportion by Geographic Area in 2024
Table 57. EndoClot Plus Polysaccharide Hemostatic Powder SWOT Analysis
Table 58. EndoClot Plus Recent Developments
Table 59. Baxter Corporation Information
Table 60. Baxter Description and Major Businesses
Table 61. Baxter Product Models, Descriptions and Specifications
Table 62. Baxter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Baxter Sales Value Proportion by Product in 2024
Table 64. Baxter Sales Value Proportion by Application in 2024
Table 65. Baxter Sales Value Proportion by Geographic Area in 2024
Table 66. Baxter Polysaccharide Hemostatic Powder SWOT Analysis
Table 67. Baxter Recent Developments
Table 68. Hemostasis, LLC Corporation Information
Table 69. Hemostasis, LLC Description and Major Businesses
Table 70. Hemostasis, LLC Product Models, Descriptions and Specifications
Table 71. Hemostasis, LLC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Hemostasis, LLC Sales Value Proportion by Product in 2024
Table 73. Hemostasis, LLC Sales Value Proportion by Application in 2024
Table 74. Hemostasis, LLC Sales Value Proportion by Geographic Area in 2024
Table 75. Hemostasis, LLC Polysaccharide Hemostatic Powder SWOT Analysis
Table 76. Hemostasis, LLC Recent Developments
Table 77. Singclean Medical Products Corporation Information
Table 78. Singclean Medical Products Description and Major Businesses
Table 79. Singclean Medical Products Product Models, Descriptions and Specifications
Table 80. Singclean Medical Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Singclean Medical Products Sales Value Proportion by Product in 2024
Table 82. Singclean Medical Products Sales Value Proportion by Application in 2024
Table 83. Singclean Medical Products Sales Value Proportion by Geographic Area in 2024
Table 84. Singclean Medical Products Polysaccharide Hemostatic Powder SWOT Analysis
Table 85. Singclean Medical Products Recent Developments
Table 86. Johnson & Johnson Corporation Information
Table 87. Johnson & Johnson Description and Major Businesses
Table 88. Johnson & Johnson Product Models, Descriptions and Specifications
Table 89. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Johnson & Johnson Sales Value Proportion by Product in 2024
Table 91. Johnson & Johnson Sales Value Proportion by Application in 2024
Table 92. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
Table 93. Johnson & Johnson Polysaccharide Hemostatic Powder SWOT Analysis
Table 94. Johnson & Johnson Recent Developments
Table 95. BD Corporation Information
Table 96. BD Description and Major Businesses
Table 97. BD Product Models, Descriptions and Specifications
Table 98. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. BD Recent Developments
Table 100. Zhonghui Shengxi Corporation Information
Table 101. Zhonghui Shengxi Description and Major Businesses
Table 102. Zhonghui Shengxi Product Models, Descriptions and Specifications
Table 103. Zhonghui Shengxi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Zhonghui Shengxi Recent Developments
Table 105. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Corporation Information
Table 106. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Description and Major Businesses
Table 107. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Product Models, Descriptions and Specifications
Table 108. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Recent Developments
Table 110. Saikesaisi Holdings Group Corporation Information
Table 111. Saikesaisi Holdings Group Description and Major Businesses
Table 112. Saikesaisi Holdings Group Product Models, Descriptions and Specifications
Table 113. Saikesaisi Holdings Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Saikesaisi Holdings Group Recent Developments
Table 115. Boz Medical Corporation Information
Table 116. Boz Medical Description and Major Businesses
Table 117. Boz Medical Product Models, Descriptions and Specifications
Table 118. Boz Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Boz Medical Recent Developments
Table 120. Key Raw Materials Distribution
Table 121. Raw Materials Key Suppliers
Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 123. Milestones in Production Technology Evolution
Table 124. Distributors List
Table 125. Market Trends and Market Evolution
Table 126. Market Drivers and Opportunities
Table 127. Market Challenges, Risks, and Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Polysaccharide Hemostatic Powder Product Picture
Figure 2. Global Polysaccharide Hemostatic Powder Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Polysaccharide Hemostatic Powder Product Picture
Figure 4. Absorbable Modified Polymer Product Picture
Figure 5. Global Polysaccharide Hemostatic Powder Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Polysaccharide Hemostatic Powder Report Years Considered
Figure 10. Global Polysaccharide Hemostatic Powder Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 12. Global Polysaccharide Hemostatic Powder Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Polysaccharide Hemostatic Powder Revenue Market Share by Region (2020-2031)
Figure 14. Global Polysaccharide Hemostatic Powder Sales (2020-2031) & (K Units)
Figure 15. Global Polysaccharide Hemostatic Powder Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Polysaccharide Hemostatic Powder Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Polysaccharide Hemostatic Powder Sales Volume Market Share in 2024
Figure 18. Global Polysaccharide Hemostatic Powder Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Polysaccharide Hemostatic Powder Revenue Market Share by Manufacturer in 2024
Figure 21. Absorbable Modified Polymer Revenue Market Share by Manufacturer in 2024
Figure 22. Global Polysaccharide Hemostatic Powder Sales Market Share by Type (2020-2031)
Figure 23. Global Polysaccharide Hemostatic Powder Revenue Market Share by Type (2020-2031)
Figure 24. Global Polysaccharide Hemostatic Powder Sales Market Share by Application (2020-2031)
Figure 25. Global Polysaccharide Hemostatic Powder Revenue Market Share by Application (2020-2031)
Figure 26. North America Polysaccharide Hemostatic Powder Sales YoY (2020-2031) & (K Units)
Figure 27. North America Polysaccharide Hemostatic Powder Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) in 2024
Figure 29. North America Polysaccharide Hemostatic Powder Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Polysaccharide Hemostatic Powder Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Polysaccharide Hemostatic Powder Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Polysaccharide Hemostatic Powder Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) in 2024
Figure 39. Europe Polysaccharide Hemostatic Powder Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Polysaccharide Hemostatic Powder Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 44. France Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Polysaccharide Hemostatic Powder Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Polysaccharide Hemostatic Powder Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Polysaccharide Hemostatic Powder Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Polysaccharide Hemostatic Powder Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 59. India Polysaccharide Hemostatic Powder Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Polysaccharide Hemostatic Powder Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Polysaccharide Hemostatic Powder Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Polysaccharide Hemostatic Powder Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Polysaccharide Hemostatic Powder Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Polysaccharide Hemostatic Powder Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Polysaccharide Hemostatic Powder Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Polysaccharide Hemostatic Powder Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Polysaccharide Hemostatic Powder Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Polysaccharide Hemostatic Powder Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Polysaccharide Hemostatic Powder Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Polysaccharide Hemostatic Powder Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Polysaccharide Hemostatic Powder Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Polysaccharide Hemostatic Powder Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Polysaccharide Hemostatic Powder Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Polysaccharide Hemostatic Powder Revenue (2020-2025) & (US$ Million)
Figure 80. Polysaccharide Hemostatic Powder Industry Chain Mapping
Figure 81. Regional Polysaccharide Hemostatic Powder Manufacturing Base Distribution (%)
Figure 82. Global Polysaccharide Hemostatic Powder Production Market Share by Region (2020-2031)
Figure 83. Polysaccharide Hemostatic Powder Production Process
Figure 84. Regional Polysaccharide Hemostatic Powder Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Polysaccharide Hemostatic Powder market?
The top companies in the global Polysaccharide Hemostatic Powder market are EndoClot Plus、Baxter、Hemostasis, LLC.
What was the global market size of Polysaccharide Hemostatic Powder in 2025?
What was the global market size of Polysaccharide Hemostatic Powder in 2031?
What is the annual compound growth rate of the global Polysaccharide Hemostatic Powder market size from 2025 to 2031?
Which region is expected to have the highest market share?
Related Reports
Polysaccharide Hemostatic Powder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 287 million in 2025 and is projected to reach US$ 483 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 128
USD 3950.00
(Single User License)
Global Polysaccharide Hemostatic Powder Market Research Report 2026
The global Polysaccharide Hemostatic Powder market was valued at US$ 287 million in 2025 and is anticipated to reach US$ 483 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 110
USD 2900.00
(Single User License)
Global Polysaccharide Hemostatic Powder Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Polysaccharide Hemostatic Powder market size was US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 77
USD 4250.00
(Single User License)
Polysaccharide Hemostatic Powder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 106
USD 3950.00
(Single User License)
Global Polysaccharide Hemostatic Powder Market Research Report 2025
The global market for Polysaccharide Hemostatic Powder was valued at US$ 269 million in the year 2024 and is projected to reach a revised size of US$ 451 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-01-13
Pages: 80
USD 2900.00
(Single User License)
Global Polysaccharide Hemostatic Powder Market Research Report 2024
A polysaccharide hemostatic powder can be used as an adjunctive hemostat to facilitate control of bleeding from capillary, venous or arteriolar vessels to address low-grade intraoperative bleeding.
Published Date: 2024-01-17
Pages: 91
USD 2900.00
(Single User License)
Polysaccharide Hemostatic Powder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 287 million in 2025 and is projected to reach US$ 483 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 128
USD 3950.00 (Single User License)Global Polysaccharide Hemostatic Powder Market Research Report 2026
The global Polysaccharide Hemostatic Powder market was valued at US$ 287 million in 2025 and is anticipated to reach US$ 483 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-04-17
Pages: 110
USD 2900.00 (Single User License)Global Polysaccharide Hemostatic Powder Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Polysaccharide Hemostatic Powder market size was US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 77
USD 4250.00 (Single User License)Polysaccharide Hemostatic Powder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 106
USD 3950.00 (Single User License)Global Polysaccharide Hemostatic Powder Market Research Report 2025
The global market for Polysaccharide Hemostatic Powder was valued at US$ 269 million in the year 2024 and is projected to reach a revised size of US$ 451 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-01-13
Pages: 80
USD 2900.00 (Single User License)Global Polysaccharide Hemostatic Powder Market Research Report 2024
A polysaccharide hemostatic powder can be used as an adjunctive hemostat to facilitate control of bleeding from capillary, venous or arteriolar vessels to address low-grade intraoperative bleeding.
Published: 2024-01-17
Pages: 91
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now